UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): August 25, 2005
ALLIED HEALTHCARE PRODUCTS, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 0-19266 25-1370721
---------------------------- ------------ -------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
1720 SUBLETTE EVENUE, SAINT LOUIS, MISSOURI 63110
--------------------------------------------------
(Address of principal executive offices)
Registrant's telephone number, including area code: (314) 771-2400
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Section 8 - Other Events
Item 8.01 Other Events.
On August 25, 2005, the Board of Directors of the Registrant authorized
repurchases of shares of the Registrant's common stock pursuant to open market
transactions in accordance with Rule 10b-18 under the Securities Exchange Act or
in privately negotiated block transactions. The authorization permits
repurchases from time to time until June 30, 2007 at the discretion of the
Chairman of the Board or the President and Chief Executive Officer. The
authorization permits up to $1,000,000 to be applied to such repurchases.
No specific number of shares are sought in connection with the
authorization.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
ALLIED HEALTHCARE PRODUCTS, INC.
Date: August 25, 2005 By: /s/ Daniel C. Dunn
-------------------------------
Daniel C. Dunn
Vice-President, Chief Financial
Officer and Secretary